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Abstract
Background: Chlamydia trachomatis infection of the female genital tract can lead to serious
sequelae resulting in fertility related disorders. Little is known about the mechanism leading to
Chlamydia induced pathology and factors responsible for it. As only some of the women develops
reproductive disorders while majority of the women clears infection without any severe sequalae,
mucosal immune response in women with or without fertility disorders was studied to identify
factors which may lead to final clinical outcome of chlamydial infection.
Methods: Myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) populations in cervical mucosa and
peripheral blood were analyzed in controls and Chlamydia positive women with or without fertility
disorders with multicoloured flow cytometric analysis. Cervical cytokines (IL-6, IL-8, IL-10, IL-12,
TNF-alpha and IFN-gamma), C-reactive protein levels and sex hormone levels in serum were
quantified by ELISA.
Results: In cervix of Chlamydia positive women with fertility disorders, significantly high (P < 0.05)
numbers of pDCs were present with increased CD80 expression. pDCs correlated significantly
with C-reactive protein levels, IL-6 and IFN-gamma levels in women with fertility disorders. In
contrast, mDCs showed significant upregulation of CD1a during chlamydial infection and
correlated significantly with IL-12 levels in Chlamydia positive fertile women. β-estradiol levels
were significantly higher in women having fertility disorders as compared to fertile women and have
significant correlations (r = 0.65; P < 0.05) with pDCs numbers, CD80 expression, IL-6 levels and
IFN-gamma levels in these women.
Conclusion: These results suggest that development of sequalae in some women can be a result
of interplay of many factors including type of dendritic cell, co stimulatory molecule expression,
cytokine secretion pattern and hormone levels.
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Background
Chlamydia trachomatis infections are the most prevalent
sexually transmitted bacterial infections worldwide [1]. In
India, a high prevalence rate of genital chlamydial infec-
tion has been reported among symptomatic women, of
which upto 30% have fertility related disorders as multi-
ple spontaneous abortions, infertility (not male related),
or sub fertility [2,3]. Spontaneous clearance of C. trachom-
atis from the lower genital tract occurs in nearly 20% of
chlamydial infections without any sequelae [4], however,
in absence of treatment, these infections often recur, or
remain persistent, leading to structural damage to the
inflamed tissue and increase the risk of developing a
sequelae [5,6]. Host factors such as type of immune
response, plays a large role in determining the course and
morbidity of C. trachomatis infections but the exact immu-
nopathological mechanism leading to Chlamydia induced
sequelae is still not well understood.
During chlamydial infection, T-cell mediated adaptive
immune responses, play a major role in the clearance and
resolution of infection [7]. T cells are activated by antigen
presenting cells as dendritic cells (DCs) which play a cru-
cial role in initiation and maintenance of T-cell immunity
[8]. Besides providing protection, DCs have also been
reported to be involved in chronic inflammation [9]. The
cervical mucosa is reported to contain numerous DCs
interdigitating between the epithelial cells [10] and these
DCs often stain positive for CD1a [11]. DCs have also
been reported to produce large amounts of interleukin-12
(IL-12) upon ex vivo pulsing with inactivated chlamydial
organisms [12].
Two major DC subsets have been described; the CD123+
DCs designated as plasmacytoid DCs (pDCs) and the
CD11c+CD123-  (-/dim) designated as myeloid DCs
(mDCs). the subsets express high levels of HLA-DR and
lack the lineage markers CD3, CD14, CD19, CD20,
CD16, and CD56, however, functional differences
between the two have been described which include T-cell
stimulatory activity, production of proinflammatory
cytokines and differential expression of co-stimulatory
molecules [13-15]. The expression of various co-stimula-
tory molecules (CD80/86) associated with DCs, have also
been reported to modulate the type of immune response
[16]. Further upon chlamydial infection, mononuclear
cells are triggered to release a number of proinflammatory
cytokines including TNF-α, IL-1, IL-6 and IL-8 [17,18] and
many studies have reported association between cytokine
profiles and immunopathogenic mechanisms. We have
also reported previously that estradiol levels can modulate
immune response in women with chlamydial infection
[19] and can have a role in Chlamydia induced pathology.
In a recent study from our laboratory [20] we have
reported that chlamydial infection recruits both mDCs
and pDCs to the cervix and suggested that pDCs may be
responsible for the immunopathogenesis of chlamydial
infection, thereby, helping in the induction of sequelae.
These results along with above facts prompted us to study
the mobilization of these DC subsets in Chlamydia posi-
tive women, with or without fertility related disorders
(multiple spontaneous abortions and infertility (not male
related) and to evaluate the role played by these DC sub-
sets in providing a protective/pathogenic immune
response. We also measured the expression of various co-
stimulatory molecules associated with these DCs and
cytokines in cervical washes. C-reactive protein (CRP) lev-
els and sex hormone levels in the sera of women with and
without fertility disorders were also studied to understand
the basic question in chlamydial pathogenesis as to why
some women clear infection while others develop seque-
lae.
Methods
Study population
After obtaining informed written consent, 153 patients
attending the gynecology outpatient department, Safdur-
jang Hospital, New Delhi, India were enrolled for the
study. Twenty eight healthy age-matched controls attend-
ing the family planning department for birth control
measures and with no previous history of any sexually
transmitted disease (STD) were also enrolled. The study
received approval from the hospital's ethics review com-
mittee. Procedures followed for sample collection were in
accordance with the ethical standards for human experi-
mentation established by the Declaration of Helsinki of
1975 (revised in 1983).
At recruitment, a detailed clinical questionnaire was
administered to each patient for collecting information
on reasons for referral, gynecology history including men-
struation, symptoms of genital and urinary tract infection,
obstetric and medical histories. Patients taking oral con-
traceptives, having positive urine pregnancy test, recent
antibiotic therapy, and history of recently treated sexually
transmitted infection and genital tuberculosis were
excluded from the study.
Women with fertility related disorders included women
with infertility and multiple spontaneous abortions.
Infertile women where identified as those, which lack rec-
ognized conception after 1.5 to 2 years of regular inter-
course without the use of contraception. Women with
multiple spontaneous abortions (more than 2) have been
described as those having delivery of pre-viable foetus
before the 20th week of gestation. Fertile women were
those having last child birth within last 4 months to 1 yearReproductive Biology and Endocrinology 2008, 6:46 http://www.rbej.com/content/6/1/46
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and testing positive for C. trachomatis during last preg-
nancy.
Since variations in sex hormones are known to influence
cytokines concentrations and immune cell populations
including the mDC and pDC [21], cervical samples were
collected during mid-cycle (median 13 days, range 9th to
15th day of the menstrual cycle). None of the patient had
sexual intercourse 3 days or more prior to collection of
sample.
Collection of samples
After cleaning the endocervix, endocervical swabs (HiMe-
dia, Mumbai, India) were collected for diagnosis of C. tra-
chomatis  and other sexually transmitted disease (STD)
pathogens. Cervical washes for determination of cervical
cytokines were collected in 5 ml of sterile saline adminis-
tered through a sterile Pasteur pipette and recovered after
thorough washing of the cervix. For collection of cervical
cells, a cytobrush was placed within the endocervical
canal so that the cells from the endocervical region and
the zone between the endocervical and ectocervical region
(transformation zone) could be obtained. Cells were then
transferred to a sterile tube containing sterile PBS (pH 7.2)
supplemented with 100 U penicillin/mL, 100 μg strepto-
mycin/mL, and 100 μg glutamine/mL. No samples were
collected from patients with friable cervix and contact
bleeding to ensure collection of cervical lymphocytes
only. Heparinized peripheral venous blood (5 mL), was
also collected after the diagnostic samples. Samples were
then stored at 4°C until, they were transported to the lab-
oratory and were then processed within 1 h.
Microbiology
Samples were confirmed for chlamydial positivity by
Direct Fluorescent Analysis (DFA) using fluorescein iso-
thiocyanate (FITC) conjugated monoclonal antibodies to
C. trachomatis major outer membrane protein (Microtrak,
Palo Alto, USA). A sample was considered to be positive
when greater than 10 elementary bodies (EB's) were
detected. DFA negative samples were further confirmed
for positivity by PCR analysis using primer specific for 517
bp plasmid of C. trachomatis [22]. Gram stained cervical
smears were examined for the presence of yeast cells (Can-
didiasis) and quantification of polymorphonuclear leuko-
cytes (PMNLs) per high-powered field (hpf) was done in
smears to ensure presence of cervicitis. Vaginal smears
were analyzed for clue cells, for diagnosis of bacterial
Vaginosis. Wet mount microscopy was performed for the
diagnosis of Trichomonas vaginalis. Neisseria gonorrhoeae,
Mycobacterium hominis and Ureaplasma urealyticum were
detected by culture as described previously [23].
Isolation of cells from cervical samples
Cervical cells were isolated from the cytobrush by vigor-
ously rotating it against the sides of the transport tube
after incubating the sample with 5 mM DL-dithiothreitol
(Sigma, St Louis, MO) at 37°C for 15 min (to reduce the
mucus component of the sample). The cell suspension
obtained was then filtered through a sterile 70 μm nylon
cell strainer (BD Biosciences, San Diego, USA) and centri-
fuged at 300 g for 10 min; the resultant pellet yielding
endocervical cells. Viability of cells was determined by
trypan blue exclusion assay. The population of epithelial
cells and lymphocytes in the cytobrush sample was
counted with a haemocytometer and samples containing
less than 1 million lymphocytes/ml were excluded.
DC identification
For identification of DCs, following monoclonal antibod-
ies (MoAb) were used: fluorescein isothiocyanate (FITC)
conjugated lineage cocktail LIN-1 (anti-CD3, anti-CD14,
anti-CD16, anti-CD19, anti-CD20 and anti-CD56),
CD123-phycoerythrin, HLA-DR-peridin chlorophyll pro-
tein (BD Biosciences). In addition, FITC labeled anti-CD4,
anti-CD8, anti-CD19 (for identification of CD4 T cells,
CD8 T cells and B cells respectively) and allophycocyanin
labeled anti-CD11c were purchased from eBiosciences
(San Diego, USA) and PE labeled anti-CD80 and CD86
(costimulatory molecules involved in diferential activa-
tion of T-helper pathways) CD83 (DC maturation
marker) and CD1a (immature DC marker) were obtained
from BD Biosciences. To measure expression of CD80, 83,
86 and 1a on CD123+ cells anti-CD123-PE-Cy5 and HLA-
DR-APC were purchased from BD Biosciences. For blood
dendritic cells, 100 μl of whole blood was incubated with
antibody cocktail for 20 min at room temperature. Eryth-
rocytes were lysed with FACS Lysing Buffer (BD Bio-
sciences), cells were washed with PBS (with 0.1% (w/v)
BSA and 0.1% NaN3) to remove unbound MoAb and
resuspended in 1%(w/v) paraformaldehyde in PBS. For
cervical cells, 100,000 cervical cells/tube were incubated
with antibody cocktail for 25 min on ice and subsequently
washed and fixed as per the protocol above. Cell prepara-
tions were labelled in parallel and included all appropri-
ate isotype control antibodies (BD Biosciences) for
establishing the demarcation between negative and posi-
tive populations. As previously described [19], cervical
specimen exhibit high level of granularity and autofluo-
rescence that could be attributed to many factors. Back-
ground fluorescence and presence of lymphocytes was
minimized by introduction of an acquisition gate on the
forward-scatter (FSC) versus side-scatter (SSC) profile,
which included most of the monocytic and dendritic cell
fraction and gave reliable differentiation of these cells
from epithelial cells, lymphocytes and cell debris. Sam-
ples were acquired using a FACS Calibur Cytometer and
analyzed with cell quest software (Becton Dickinson).Reproductive Biology and Endocrinology 2008, 6:46 http://www.rbej.com/content/6/1/46
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DCs were identified as lineage FITC cocktail negative and
HLA-DR positive population. The gating strategy used to
identify and quantify LIN-/DR+ cells is described in Figure
1.
mDCs and pDCs in cervical secretions were measured as
number of events present per 100,000 cells taken for
experiment. This number was then adjusted according to
the total number of cells obtained in that cervical sample.
Quantification of dendritic cell subsets in cervical mucosa by flow cytometric analysis Figure 1
Quantification of dendritic cell subsets in cervical mucosa by flow cytometric analysis. (A) Introduction of an 
acquisition gate (R1) on the forward-scatter (FSC) versus side-scatter (SSC) profile to select mononuclear cell population. (B) 
cervical DCs were identified within gate R2 as lineage fluorescein isothiocyanate (FITC) cocktail (contains anti-CD3, CD14, 
CD16, CD19, CD20, and CD56) negative and HLA-DR positive. (C-D) Detection of HLA-DR+ CD11c+ myeloid DCs and 
HLA-DR+CD123+ plasmacytoid DCs respectively. FSC, forward scatter; SSC, side scatter; PerCP, peridin chlorophyll protein; 
PE, phycoerythrin; APC, allophycocyanin.
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These were finally presented as number of events per cer-
vical sample. In case of blood the dendritic cell subsets
were counted as events per 100 μl of blood taken and were
then calculated and represented as events per milliliter of
blood.
Quantification of cytokines in cervical washes
Quantification of IL-4, IL-6, IL-8, IL-10, IL-12, TNF-α and
IFN-γ was done using commercially available ELISA kits
(eBiosciences, San Diego, CA), in accordance with the
manufacturer's instructions. Briefly, 96-well ELISA plates
were coated overnight with antihuman IL-4, IL-6, IL-10,
IL-8, IL-12, TNF-α and IFN-γ capture antibodies.
Unbound coating antibody was removed, and nonspecific
protein binding sites were blocked with assay diluent as
per the manufacturer's instructions. Duplicate serial dilu-
tions of test samples or controls were incubated for 2 h at
ambient temperature. Detector antibodies were added
and incubated for 1 h, followed by incubation with perox-
idase-conjugated antimouse IgG for 30 min. For color
development, tetramethylene benzidine was added and
then stopped after 15 min by the addition of 1 N sulfuric
acid. Absorbance was read at 450 nm with reference
absorbance of 650 nm. A log log standard curve was gen-
erated, and unknowns were interpolated. The sensitivities
of cytokine kits were 1 pg/mL.
Determination of C-reactive protein levels
C-reactive protein levels in sera were measured by com-
mercially available hs-CRP ELISA kit (Calbiotech, USA)
and levels above 2 microgram per millilter were consid-
ered to show higher risk of chronic inflammation as per
the manufacturer's instructions.
Hormonal assay
Levels of β-Estradiol and progesterone in sera of patients
and controls were measured using commercially available
ELISA kits (DRG, International Inc, USA) as per the man-
ufacturer's instructions.
Statistical analysis
The Kruskal-Wallis non parametric test was used to com-
pare continuous variables among multiple groups. Cate-
gorical variables were compared using χ2 test. Correlation
was determined with spearman's correlation coefficient. P
< 0.05 was considered to be significant.
Results
Study population
Cervical C. trachomatis infection was diagnosed by Direct
Fluorescence Assay/PCR in 65 patients. Nine of these
patients were co-infected either with Candida spp., bacte-
rial vaginosis, T. vaginalis, M. hominis, U. urealyticum, or
with  N. gonorrhoeae and were thus excluded from the
study. Two Chlamydia positive patients were excluded due
to lower mononuclear cell count (less than 1 million cell/
ml). Chlamydia positive women were divided into two
groups: (a) Chlamydia positive fertile women (n = 34) and
(b) Chlamydia positive women with fertility related disor-
ders (n = 20). No significant differences in the median
ages of the patients (fertile and with fertility disorders) or
controls was observed (27, 27 and 28 years respectively).
Immune cell population in the cervix
Flowcytometric analysis demonstrated the presence of
mDCs, pDCs, CD14+ monocytes, CD3+CD4+ T cells and
CD3+CD8+ T cells in both the Chlamydia positive groups
and controls. The median range of CD3+CD4+ T cells and
CD3+CD8+ T lymphocytes among endocervical leucocytes
in women which were included in the study was between
59% and 86% that of B lymphocytes was between 1% and
4%. Significant increase was seen in the mean number of
CD4+ T-lymphocytes per 10,000 events in cervical mucosa
of fertile women compared to women with fertility disor-
ders and controls (2195 versus 401 and 262 respectively; P
< 0.05). In contrast, the CD8+ T cell population in cervical
mucosa was found to be high during chlamydial infection
but was non significant compared to controls. The
number of CD14+  monocytes per 10 000 events was
found to be significantly increased in women with
chlamydial infections compared to controls (324 versus
312 and 147; P < 0.05 for fertile women, women with fer-
tility disorders and controls respectively).
mDC and pDC population in cervical mucosa and 
peripheral blood
The median and range of absolute numbers of mDCs and
pDCs are given in Table 1. Healthy controls have signifi-
cantly lower number of mDCs and pDCs in their cervical
samples as compared to Chlamydia positive patient groups
(P < 0.01). In comparison to cervical samples there was
significant decrease in the absolute numbers of pDCs/mL
of blood in women infected with Chlamydia when com-
pared with controls. The decrease in pDC number in
blood was found to be more pronounced in case of
women with fertility disorders. In cervix of both the
Chlamydia positive groups, the median number of pDCs
was found to be higher than mDCs and was significant in
case of women with fertility disorders (P < 0.05) (Table 1).
In controls the median number of mDCs was higher to
pDCs but the difference was not significant (Table 1).
Expression of cell surface markers on mDC and pDC in 
cervical mucosa
In cervical mDCs of Chlamydia positive fertile women and
on pDCs of Chlamydia positive women with fertility disor-
ders, significantly high expression of CD80 was observed
compared to the controls (P < 0.05). Expression of CD83
was significantly higher on both cervical mDCs and pDCs
compared to controls. The expression of CD83 on pDCsReproductive Biology and Endocrinology 2008, 6:46 http://www.rbej.com/content/6/1/46
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obtained from women with fertility disorders was signifi-
cantly higher than that of pDCs obtained from fertile
women. CD86 expression on both mDCs and pDCs was
found to be lower in Chlamydia positive women with or
without fertility disorder, compared to controls but the
difference was not significant (Table 2). Expression of
CD1a on mDCs was significantly higher (P < 0.01) in
Chlamydia positive groups as compared to controls (Table
2). The expression on pDCs of CD1a was higher in of
Chlamydia positive groups compared to controls but was
non significant.
Concentration of cytokines in cervical washes and their 
correlation with DC populations
The median levels of IL-6, IL-8, IL-10, IL-12, TNF-α and
IFN-γ in cervical washes of controls and Chlamydia posi-
tive women are shown in Table 3. Significantly higher lev-
els of IL-6, IL-8, Il-10 and IFN-γ (P < 0.05) were observed
in Chlamydia positive women with fertility disorders com-
pared to Chlamydia positive fertile women and controls
(Table 3). IL-12 levels were significantly higher (P < 0.05)
in Chlamydia positive fertile women compared to both the
other groups. No significant difference between TNF-α
levels in different groups was observed (Table 3). IL-4 was
below detectable limits in all the cases.
Significant correlation (r = 0.65; P <0.05) was observed
between number of mDCs/cervical sample and levels of
IL-12 in Chlamydia  positive fertile women. Number of
pDCs/cervical sample in women with fertility disorders
showed significantly high correlation with IL-6 levels (r =
0.78; P < 0.01) and IFN-γ levels (r = 0.58; P < 0.05). A less
apparent correlation of IL-8 levels with pDCs/cervical
sample in women with fertility disorders was observed (r
= 0.41). CD80 expression on cervical mDCs from Chlamy-
dia positive fertile women showed correlation with IL-12
levels (r = 0.56; P < 0.05). CD80 expression on pDCs from
Chlamydia positive women with fertility disorders showed
significant correlation with both IL-12 and IFN-γ levels (r
= 0.73; P < 0.01 and r = 0.88; P = 0.001 respectively).
CD86 levels showed significant correlation with IL-10 lev-
els (r = 0.62; P < 0.05).
Correlation of mDC and pDCs/cervical sample with C-
reactive protein levels and sex hormone levels
Median CRP levels were found to be significantly higher
in women with fertility disorders (Table 4) and showed
significant correlation with pDCs/cervical sample (r =
0.63, P < 0.05). No correlation was found between
number of mDCs/cervical sample and CRP levels. Estra-
diol or progesterone levels were considered positive if
higher than > 2SD of the mean obtained from control
patients. Number of estradiol positive women was signif-
icantly high among women with fertility disorders (65%,
13/20) compared to fertile women (15%, 5/34). Median
estradiol levels were also found to be significantly higher
in women with fertility disorders (Table 4). Estradiol lev-
els further showed significant correlations with pDC
numbers in women with fertility disorders (r = 0.65; P <
0.05), with CD80 expression (r = 0.74 and r = 0.58 for
Table 1: Absolute median numbers of LIN-DR+ CD11c+ (mDCs) and LIN-DR+CD123+ (pDCs) dendritic cells in cervix (per cervical 
sample) and peripheral blood (per milliliter) of Chlamydia trachomatis positive and negative women.
CT Positive Fertile
(n = 34)
CT Positive with Fertility Disorders
(n = 20)
Control
(n = 28)
mDCs Blood 6300 (276–24734)¶ 8138 (175–17525) 15834 (3148–57180)
Cervix 1254 (0–9634)¶ 1856 (21–8473)¶ 28 (0–437)
pDCs Blood 6728 (4637–23820)¶ 2645 (969–8657) 12857 (3051–45496)
Cervix 1849 (0–50378)¶ 3483 (54–10845)¶# 17 (0–195)
Note: CT-Chlamydia trachomatis; ¶P < 0.05 compared to controls; #P < 0.05 compared to mDCs in cervix of Chlamydia positive women
Table 2: The percentage expression of various co-stimulatory molecules on the surface of mDCs and pDCs subsets in cervical mucosa.
% expression on mDCs % expression on pDCs
CT+ Fertile
(n = 34)
CT+ with FD
(n = 20)
Controls
(n = 28)
CT+ Fertile
(n = 34)
CT+ with FD
(n = 20)
Controls
(n = 28)
CD80 16.0 ± 3.0a 12.0 ± 2.2 7.0 ± 0.06 8.0 ± 0.7 32.5 ± 2.5b 6.0 ± 0.5
CD83 23.0 ± 0.6a 28.0 ± 1.8a 11.0 ± 2.0 18.0 ± 2.0a 38.0 ± 2.4b 8.0 ± 0.7
CD86 62.0 ± 7.0 59.0 ± 2.6 82.0 ± 5.0 21.0 ± 4.0 20.0 ± 1.9 31.0 ± 2.0
CD1a 43.0 ± 3.0a 37.0 ± 3.8a 18.0 ± 3.0 45.0 ± 3.0 41.0 ± 2.7 28.0 ± 1.0
Note: CT-Chlamydia trachomatis; FD-Fertility Disorders. The data are means ± SD. To study expression of various costimulatory molecules on 
mDC and pDC subsets, the gate was set on LIN-DR+ cells, and LIN-DR+ cells are again evaluated on quadrants having one axis as FL-2 (having Abs 
for costimulatory markers); aP < 0.01 compared to controls; bP < 0.01 compared to controls and CT positive fertile women.Reproductive Biology and Endocrinology 2008, 6:46 http://www.rbej.com/content/6/1/46
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both Chlamydia positive women with or without fertility
disorders respectively). IL-6 and IFN-γ levels also showed
significant correlation with estradiol levels in women with
fertility disorders (r = 0.49 and 0.73 respectively). No sig-
nificant difference in the level of progesterone was found
among different groups (Table 4) Further, no correlation
was observed between progesterone levels and any of
parameters studied.
Discussion
In women, chlamydial infections are often asymptomatic,
and subsequent reinfections lead to inflammatory
responses with pathological sequelae [24]. In peripheral
circulation, majority of LIN-/DR+ DCs cells express either
CD11c or CD123 molecules [25,26], but no information
is available on presence and role of these subsets during
chlamydial infection. In this study, median number of
pDCs in the cervix was found to be significantly higher
than mDCs in both the Chlamydia positive groups. The
number of cervical mDCs was significantly higher in fer-
tile women in contrast to number of pDCs which were
much higher in women with fertility disorders. These
results depict that different pathological conditions are
associated with different phenotype of dendritic cells and
in women having sequelae to chlamydial infection, pDCs
outnumber mDCs in the cervix. A previous study has also
demonstrated enhanced number of pDC count in bron-
choalveolar lavage fluid of immunocompetent patients
with pneumonia [27]. Another study by Hartmann et al.,
have also shown high number of pDCs in patients with
upper respiratory tract infection [28]. In comparison to
mDCs, high number of pDCs were reported to be present
in synovial fluid from patients with spondyloarthropathy
[29]. We have also reported [20] higher number of mDCs
in Chlamydia positive women with non-inflamed cervix
compared to pDCs which were abundant in inflamed cer-
vix. Beulens et al., have originally described mDCs as
functionally mature DCs with a strong T cell stimulatory
capacity [30] and have been reported to induce protective
immune response [25], whereas, pDCs are generally
defined as tolerogenic dendritic cells. Thus, these results
collectively suggests that mDCs provide protective
response while pDCs are involved in pathogenesis but
how they help in development of a disorder is not well
understood.
As for immune modulation by costimulatory molecules,
previous studies have demonstrated that CD80/CD86 co-
stimulatory molecules differentially activate TH1/TH2 type
pathway and act as co-stimulatory signals for generation
of TH1/TH2 cells CD4+ T cells [30,31]. It has been shown
previously that silencing of CD80 expression on dendritic
cells significantly decreases IFN-γ secretion while that of
CD86 decreases IL-4 secretion [32]. CD86 has also been
shown to stimulate IL-10 production in CD4+ T cells [33].
Significantly high expression of CD80 molecules on pDCs
obtained from women with fertility disorders and on
mDCs from fertile women was observed. This suggests
that significantly high expression of CD80 may lead to
increased activation of TH1 cells during Chlamydial infec-
tion. As no difference in expression levels of CD86 among
different groups was observed it suggests that CD86 may
not be involved in induction of immune response to C.
trachomatis.
Table 3: Cytokine concentrations in cervical washes of Chlamydia positive women and controls.
Control CT positive fertile women CT positive women with fertility Disorder
IL-6 34.97 (04.5–418.0) 19.83 (36.4–598.3) 74.47 (23.7–1674.8)#
IL-8 89.9 (UDL-247.57) 137.4 (13.7–375.9) 551.58 (32–1074.0)#
IL-10 07.57 (UDL-20.5) 09.27 (UDL-36.0) 27.94 (UDL-105.98)#
IL-12 127.16 (105.7–279.8) 294.62 (136.0–275.2)# 148.51 (89.5–602.9)
IFN-γ 115.91 (95.1–489.5) 164.37 (103.4-573.7) 347.96 (144.1–460.3)#
TNF-α 102.15 (34.8–356.1) 102.93 (59.8–418.4) 101.97 (93.2–507.0)
NOTE. Data represent median values. Figures in parentheses depict range. CT, Chlamydia trachomatis; Dis, Disorders; UDL-Under detection limit
# P < 0.05 compared to other groups by Mann Whitney U test
Table 4: Levels of β-estradiol, CRP and Progesterone in serum of controls and Chlamydia positive women.
β-estradiol CRP Progesterone
Control 205 (142–257) 1.06 (UD-2.05) 3.6 (0.2–4.8)
Fertile 153 (73–154) 1.13 (UD-2.27) 4.1 (0.1–6.1)
Fertility Disorders 207 (156–243)# 3.95 (0.57–11.84)# 3.8 (0.1–5.7)
NOTE. Data are median levels of β-estradiol and CRP in picograms per milliliter and nanogram per milliliter respectively. Figure in parentheses 
denote range.
#P < 0.05 compared to other groupsReproductive Biology and Endocrinology 2008, 6:46 http://www.rbej.com/content/6/1/46
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Further, our results showed significantly higher expres-
sion of CD83 on both cervical mDCs and pDCs compared
to controls. In comparison to mDCs the expression was
significantly high on pDCs from women with fertility dis-
orders. CD83 expression is taken as a marker for pheno-
typic maturation of dendritic cells and higher percentage
of DCs expressing them in both Chlamydia positive cases
show that during chlamydial infection high number of
both mDC and pDC take up antigen for processing and
turn into mature DCs. This data suggests that although
both mDCs and pDCs are present in the cervix of women
with fertility disorders but still pDCs are the ones which
are more matured and hence activated.
When cervical washes were studied for cytokine concen-
trations it was seen that in Chlamydia  positive women
with fertility disorders significantly higher levels of IL-6,
IL-8, IL-10 and IFN-γ were present compared to the other
groups. In comparison to this IL-12 levels were signifi-
cantly higher in Chlamydia  positive fertile women.
Although not as protective as IFN-γ, IL-6 (generated either
by epithelial cells or by the interaction of chlamydiae with
T lymphocytes) is probably important, together with IL-
12, for sustaining the protective T-helper 1 cell mediated
immune response [34]. Although protective in nature,
pathogenic role of IL-6, has been shown previously
[35,36]. In earlier study increased IL-6 levels during in
silent tubal infections of C. trachomatis have been reported
[37]. As for IL-8, it has also been shown previously that
synovial tissues from chronic arthritis patients with syno-
vial  C. pneumoniae infection have significant levels of
mRNA for IL-8 [38]. These results suggest that IL-6 and IL-
8 may be involved in chlamydial pathology but their
actual role and mechanism is yet to be ascertained.
IL-10 was found to be up-regulated in cervical washes
obtained from Chlamydia positive women with fertility
disorders. IL-10 is not always an inflammatory/inhibitory
cytokine; instead higher levels of IL-10 probably prevent
the pathological effect of the inflammatory cytokines like
IL-1β, IFN-γ and TNF-α. IL-10 can create a favourable
environment for persistence of microbes by down-regulat-
ing the proinflammatory cytokines. In case of chlamydial
infection IL-10 has been reported to be associated with
typical pathological changes like fibrosis and granuloma
formation [39]. In case of ocular chlamydial infection, IL-
10 has been shown to be associated with scarring and
blindness [40]. Association of increased frequency of IL-
10 detection in endocervical secretions of women with
non-ulcerative STDs, like C. trachomatis have suggested
that this may be a potential mechanism through which
these infections may alter susceptibility to HIV-1 infection
[41]. These results along with ours, suggests, that excessive
secretion of IL-10 may lead to either incomplete clearance
of bacteria or may develop a state of anergy resulting in
development of fertility related disorders.
IL-12, on the other hand was significantly higher in
Chlamydia  positive fertile women compared to other
groups. IL-12 is derived from dendritic cells and mono-
cytes and it induces TH1 differentiation with induction of
IFN-γ [42]. These results suggest that high secretion of IL-
12 may be responsible for providing a protective immune
response to chlamydial infection.
IFN-γ levels were found to be significantly higher in
women with fertility disorders as compared to other
groups. A previous study by our group [19] have shown
also high levels of IFN-γ in cervical washes of women with
recurrent chlamydial infections compared to women with
primary chlamydial infections and has demonstrated that
high secretion of pro-inflammatory cytokines as IL-6, IFN-
γ and TNF-α lead to acute inflammation and can thus
cause reproductive disorders. An earlier study by Van
Voorhis et al., 1997 has also shown that repeated chlamy-
dial infection in a Macca nemestrina model high levels of
IFN-γ transcripts were produced [43]. Further, in synovial
tissue of patients with C. trachomatis associated arthritis,
both IL-10 and IFN-γ producing cells were detected and it
was suggested that excessive IL-10 production suppresses
IFN-γ and mediated persistence [44].
High expression of CD80 on mDCs and its significant cor-
relation with IL-12 levels in fertile women further suggest
that the major role of mDCs is in clearance of the organ-
ism from the genital tract. On the other hand, CD80
expression on pDCs of women with fertility disorders
showed significant correlation with both IL-12 and IFN-γ
levels suggesting the role of CD80 activation in secretion
of type 1 cytokines. Further, these results suggest that
modulation of cytokine expression can be the main mech-
anism which decides whether the infection is cleared or
will go for pathological damage. This would however, be
hypothetical as there is no confirmation that in women
with fertility related disorders the clinical condition is due
to chlamydial infection and not due to any other cause.
The results we got above may shed a new light on chlamy-
dial pathogenesis but these have their limitations as; (1)
scarcity of cell numbers making it impossible for us to
separate these subsets and then see the expression of
cytokines upon stimulation with C. trachomatis as
increased number of pDCs can act as a factor acting to
limit bacterial load and pathogenesis (2) the fact that
cytokines like IL-6, IL-8 and IL-12 are secreted by other
cell populations like macrophages and epithelial cells
which outnumber DCs in the cervix.
Further, median CRP levels were found to be significantly
higher in women with fertility disorders and showed sig-Reproductive Biology and Endocrinology 2008, 6:46 http://www.rbej.com/content/6/1/46
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nificant correlation with pDCs. CRP levels are considered
marker for inflammation and its association with pDCs in
women with fertility disorders suggests that pDCs are
involved either in induction or in maintenance of inflam-
matory responses.
We detected significantly high levels of estradiol in
women with fertility disorders, which correlated signifi-
cantly with pDC levels, CD80 expression and IL-6 and
IFN-γ secretion. In a previous study in humans it has been
shown that women are more susceptible to chlamydial
infection under β-estradiol influence, since more chlamy-
dial organisms can be isolated during the proliferative
part of the cycle [45]. Estrogen was also found to enhance
chlamydial adherence or intracellular development of
their inclusion [46]. This suggests that estradiol may
enhance inflammation by helping in increased secretion
of proinflammatory cytokines either by up-regulating
CD80 expression or by modulating the cytokine secretion
profile of other cell. A previous study by Dimayuga et al.,
[47] has also shown up-regulation of CD80 expression in
LPS stimulated microglial cells by estrogen treatment.
Overall these results show that high estradiol levels may
help in persistence of Chlamydia directly by helping in its
intracellular development or indirectly by modulation of
cytokine secretion profile of immune cells.
Conclusion
Overall, our data suggests that a differential activation of
subsets of DC, cytokine secretion pattern and hormonal
levels can be responsible for modulating the immune
response to chlamydial infection, but, the question that
still remains unanswered is the mechanism by which
these are modulated during chlamydial infections and
this deserves further elucidation. Since there is an urgent
need to develop a vaccine against chlamydial infection,
therefore, the basic research challenge is to understand the
requirements for inducing and maintaining protective
genital mucosal immunity.
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